Stellantis 2025 Results Mark First Annual Loss

Stellantis 2025 results show its first annual loss after EV writedowns, suspending the dividend and authorizing hybrid bonds to shore liquidity.

February 26, 2026·2 min read
View all news articles
Flat vector of a fractured car shell on a light amber-sand gradient symbolizing Stellantis 2025 results and EV writedowns.

KEY TAKEAWAYS

  • Stellantis reported its first annual net loss driven by €25.4 billion in unusual charges.
  • Board suspended the dividend and authorized hybrid bonds to preserve the balance sheet.
  • Guidance targets mid-single-digit net revenue growth and a low-single-digit AOI margin.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Stellantis (STLA) reported its first annual loss in 2025 after electric-vehicle (EV) writedowns and a strategic reset, aiming to restore profitability through a new product wave and operational improvements in 2026.

Full-Year Results and Charges

The company said in a press release on Feb. 26, 2026, that full-year net revenues fell 2% from 2024 to €153.5 billion, pressured by foreign-exchange headwinds and pricing declines in the first half. Revenues rose 10% in the second half.

Stellantis posted a net loss of €22.3 billion, mainly due to €25.4 billion in unusual charges. On Feb. 6, the company flagged about €22.2 billion of second-half charges excluded from adjusted operating income. These covered an EV supply-chain reset, product-plan adjustments, warranty-estimation changes, and workforce reductions in Enlarged Europe, including roughly €6.5 billion in cash payments over four years.

Adjusted operating income showed a loss of €842 million, with a margin of about -0.5%. Industrial free cash flow was negative €4.5 billion for the year. The second half improved by 50% from the first half to negative €1.5 billion and was 73% better than the second half of 2024.

Consolidated shipments rose 1% to 5.484 million units for the year, with second-half shipments up 11% year-over-year.

Strategic Reset and Product Pipeline

Stellantis announced a strategic reset to prioritize customer freedom of choice across electric, hybrid, and internal-combustion technologies. The company is scaling back some EV investments while accelerating a new product wave. This includes the Jeep Cherokee, Dodge Charger SIXPACK in North America, Ram Dakota in South America, Citroën C5 Aircross BEV, Jeep Compass BEV, and Fiat 500 Hybrid for Enlarged Europe.

2026 Guidance, Liquidity, and Governance

For 2026, Stellantis set guidance for mid-single-digit net-revenue growth, a low-single-digit adjusted operating income margin, and year-over-year improvement in industrial free cash flow. The outlook includes about €2 billion in payments related to the second-half 2025 charges and assumes progressive improvement from the first to the second half of the year. Management described the guidance as unaudited and contingent on strong execution of the new product wave, quality improvements, and regional normalization, including North American inventory adjustments and targeted mid-SUV and internal-combustion engine re-entries.

To preserve its balance sheet, the board authorized suspending the 2026 dividend and issuing up to €5 billion in hybrid bonds. The company ended 2025 with €46 billion in industrial available liquidity and expects positive industrial free cash flow in 2027. Upcoming investor events include the Annual General Meeting on April 14, 2026, and Investor Day on May 21, 2026.

"Our 2025 full year results reflect the cost of over-estimating the pace of the energy transition," said CEO Antonio Filosa.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Taco Bell Lettuce Outbreak Prompts Probe

Taco Bell Lettuce Outbreak Prompts Probe

Taco Bell lettuce outbreak led to ingredient removals and a federal probe, investors watching supply-chain and brand risk that could pressure shares.

SpaceX Starship Launch Abort Scrubs Flight 13

SpaceX Starship Launch Abort Scrubs Flight 13

SpaceX Starship Launch Abort delayed Flight 13 after engine-start failures, raising operational uncertainty that clouds near-term launch cadence.

Alcoa Q2 Results Show Record Revenue, Alumina Cut

Alcoa Q2 Results Show Record Revenue, Alumina Cut

Alcoa Q2 results showed record revenue and higher adjusted profit but missed consensus and cut 2026 alumina guidance, tightening supply expectations.

Netflix Q2 2026 Earnings Cut Viewing Data, Trim Guidance

Netflix Q2 2026 Earnings Cut Viewing Data, Trim Guidance

Netflix Q2 2026 earnings showed a slight revenue miss and below-Street Q3 guidance; cutting viewing-hours reports raises scrutiny of engagement and models.

Merck Lipfendra FDA Approval Expands Portfolio

Merck Lipfendra FDA Approval Expands Portfolio

Merck Lipfendra FDA approval adds the first oral PCSK9 pill to Merck's portfolio and a $315 list price could shape adoption and payer positioning.

Alphabet Q2 2026 Earnings Preview

Alphabet Q2 2026 Earnings Preview

Alphabet Q2 2026 earnings preview sees traders watching Cloud growth and AI monetization as analyst price target raises shape prereport positioning.